FDA Clears AVI’s HydroPICC

MassDevice: Access Vascular, a medical device company reinventing venous access using proprietary material technology designed to reduce thrombus accumulation, announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its lead product.

Previous
Previous

A Novel Thromboresistant Hydrogel Material for Vascular Access

Next
Next

AVI Raises $3.7M to Support HydroPICC